Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Weird analysis
Conflation of "Float" with "Outstanding Shares" and claiming a normal, natural increase in float.
Dilution is defined as an increase in the outstanding shares. Linking Float to dilutions, is strange.
My finance professor would call those definitions very......Weird.
Those definitions - so incredibly Weird
Float is the normal and natural maturing of shares.
"Dilution" - is the issuance of new shares. Total outstanding shares is unchanged since Oct 2020.
Also, ENZC is close to hitting limit on Authorized Shares. There would have to be a board meeting to increase the amount of Authorized.
Again with the Weird Definitions....
"Outstanding shares" does not equal "float"
Unrestricted shares are normal and natural and have been disclosed for a long time.
I agree 100% with Cuda
"The great thing about ENZC with it's bloated share structure is that no matter the "earth shattering" news all we can seem to get is a 0-6% move......now i'm no math genius but im guessing that it would take several hundred years at that rate to ever see a dollar.....LOL"
Let's talk about "Weird Definitions"
That is a Weird Definition problem. “Float” and “Outstanding Shares” are falsely conflated. No one disputes that Outstanding Shares is unchanged - it’s clear from the documents that this is so. No new shares - NOT DILUTIVE.
The fake issue is whether “Float” is changed and that it matters. The change in float is the natural maturing and removal of restrictions on previously issued Restricted shares. Normal and natural - but, NOT DILUTIVE.
Let's keep our heads here and not be so wrong all the time.
No dumping, Outstanding shares unchanged in past year+
No "float", no dilution - enough with the garbage.
There is a long string of documents (which will be summarized shortly) showing zero dilution.
It's sad that some people think that they get away with this. Look at the documents
Those shares were unrestricted as part of a court settlement - a settled debt program completed 4 years ago - in 2018.
Nice try, though!
Onward!
Zero dilution
How can there be shares dumped when it's not disclosed?
Last 4 reports - March/21, June/21, Sept/21 and end of year 2021 - zero change in outstanding shares. Therefore, zero dilution.
Onward!
In fairness, ENZC is a pre-revenue bio-tech company.
Lots of weirdness, but with all the positive things going on (Bulgaria partnership, RobustoMed, Samsung, and all the statements made by Chandra on the pod + all the PR's).
On fundamentals only, with no revenue, company is worth little. BUT, we are all betting on the upside - which is substantial.
I am a believer, there is too much positive smoke not to be.
Onward.
Stop making things up!
There are no unrestricted shares being "dumped", LOOK AT THE DISCLOSURES. Certainly not "billions"
Please check filings. An audit and normal accounting can be done by separate firms and in fact, usually are. There is ZERO indication that any accounting firm was fired. If Malone and Bilay had been fired there would have been a required disclosure.
Stop making things up.
Rosetta is NOT a subsidiary of ENZC
Rosetta has a business relationship with ENZC, but they are not part of ENZC, Represents a huge opportunity for ITV-1 and ENZC when the victims of HIV are treated with Immunothearapy.
Rosetta Lifecare contracted delivery to Africa next year a large batch of Enzolytics Inc.'s product ITV-1. It will be used in hospitals, in complex therapy for AIDS. In hospitals and for life-threatening diseases (with consent of the patient) ITV-1 will not require registration.
Onward!
These shares were free trading when they were transferred - check the disclosures. Looks to me like Livingston has been out of the market since 12/31/2020. Livingston converted and sold between March and October/20 - nothing in 2021.
There has not been any convertible debt since 12/2020 - thus, no one is cashing in. All convertible debt was from funds received by the company so there was skin in the game. Float has not gone up between June and September 2021.
The balance of the restricted shares should age this quarter. But, that does not mean the restrictions will be taken off. Livingston's were a 3(a)10 program where a federal court order authorized the removal of the restrictions.
(sigh) There are no new shares.
The shares mentioned are all from shares aged over year ago. No new shares issued.
Come on guys, please post responsibly.
Onward!
Misinformation correction - no reports of selling
The restricted shareholders are the Officers - they cannot sell without disclosure. There has been no disclosure. In fact, CC has purchased shares as revealed in the second quarter filing. Series C.
All the other shares are already in the float of you check the last filings. There have been no new shares issued since October of 2020.
This is what I was talking about!
Summarized better than I did
To clarify, regarding pages 4-7
Those shares were all issued for convertible debt. Once the shares are issued, the obligation ceases. The debt is satisfied. There is no NEW convertible debt (see Schedule B on page 7-8). In fact, there is no debt. . Thus, no dilution.
The disclosure said no dilution.
Where is the evidence of dilution? There is no convertible debt, all preferred shares that are convertible have not decreased since 12/20 AND no new common shares have been issued since 10 of 2020.
People need to absorb the breadcrumbs.
Onward!
Thoughts on yesterday's PR - Non EMA targets.
"The Company has recently received invitation for the immediate application of this therapeutic in regions where EMA approval is not required. Accordingly, the production of ITV-1 for this purpose is moving forward.
This is kind of interesting. Wish they would expand on this.
Thoughts on yesterday's PR - Artificial Intelligence
"ENZC has fully analyzed over 87,000 HIV isolates using A.I. and over 2 million COVID-19 isolates to identify conserved epitopes. Antibodies are being produced targeting these conserved sites."
Including Omicron!
"The Company has also now completed its analysis of isolates of the Omicron Variant and has confirmed that the conserved epitopes previously identified by the Company are also fully conserved in the Omicron Variant."
There is so much detail in this PR that was missed first time. All I can say is: Wow.
Onward!
"Where EMA approval is not required"
Check out this breadcrumb - from today's PR.
"The Company has recently received invitation for the immediate application of this therapeutic in regions where EMA approval is not required. Accordingly, the production of ITV-1 for this purpose is moving forward."
Wow.
Onward, and onward!
Dr. Chandra article on AI
Nice article here (has he moved to Denver?)
https://www.the-yuan.com/177/Demystifying-the-Human-Microbiome-Using-AI.html
More breadcrumbs.
Onward!
Mongol Horde showing is colors this morning.
Zero information, just a giant, round confluence of....something...what the word? Starts with a J...ends with an "erk".
New variants of Covid directly addressed 9 months ago, new distribution, agreements with major companies. Significant progress and the market moving in ENZC direction.
Onward!
Eleven Newly Identified Conserved Target Sites of Covid
In conjunction with Intel, and with the use of AI, ENZC announced this in FEBUARY.
In simple terms, this means that the ENZC (patented!) human-cloned monoclonal antibodies should work on all variants of Covid.
We all need to absorb previous PR's - there is gold in there. Some would say...breadcrumbs.
Onward!
The Bulgarian "back door" is an ENZC asset
And, it's one that is a competitive advantage versus potential competitors. Other companies don't do it, because, unlike Harry Z., they are not directly connected to the son of a famous Bulgarian researcher. (BTW, most of the research on the patents was done with South African patients).
Bulgarian medicine and medical infrastructure is highly respected in the region and they are a key part of the EMA. ENZC is just implementing smart business strategy.
Onward!
Don’t be fooled, this is a holiday dip.
Samsung, the vet market, North American distribution, AI. All good stuff. No new issues shares.
Onward!
Once more news comes out, 0.135 will be long in the rear view mirror.
Bigger Picture.
1) two PR's in the past week or so, after 4-5 months with nothing - definitely positive. The CC muzzle seems to be off.
2) No new shares issued in past year - anyone else to said so was...er...feeding "misinformation"
3) Samsung announcement did not come from ENZC, but from Samsung - very credible.
4) Announcement on US/North America operations
5) Announcement on Veterinary initiatives - all good.
And Timing101's summary in post 132866 was outstanding.
Onward!
Fantastic summarizing of facts
This is the motherlode of breadcrumbs. Timing101, thanks for summarizing.
One key note that I need to add- there have been ZERO new shares issued in all of 2021.
It's literally the first thing mentioned.
https://www.otcmarkets.com/otcapi/company/financial-report/311215/content
Onward!
Look at these headlines:
Zero dilution since December 31, 2020. In the first page of the disclosure, it's 100% evident that there is zero dilution, therefore zero pump and dump.
Two Samsung agreement disclosed.
RobustoMed funded.
No issues with auditors.
Holy cow, this confirms everything we thought.
And, based on Dr. Chandra's comments, it looks like we will have a product in the market in 2022.
Onward!
I believe, that Dr. Chandra was referring to acquiring the rights from Enzoimmune. This is the only thing that makes sense.
Good information in post 132839 https://investorshub.advfn.com/boards/read_msg.aspx?message_id=166768050
ITV-1 is an injectable. Enzoimmune is a nutraceutical. Please don't confuse the two, they have two separate functions. The injectable is a treatment for HIV/AIDS, the nutraceutical is for immune boosting. Nutraceutical requirements for approval are much easier, as evidenced by the FDA assigning a NDI number for the compound in the 2017/2018 timeframe.
ENZC brought the lawsuit . Savov has the option of responding, or having a summary judgement against him. The lawsuit is a good thing for ENZC (an ASSET!!) - against someone who probably set up those fake websites.
No one can do anything about fake websites...
There is a company selling this product in other parts of the world, probably where ENZC has a signed distribution agreement. This is progress!
As Dr. Chandra alluded to: ENZC will have a product in the US market, probably the spray/drop. People are waiting for this product, due to the purported, clinically-tested improvements to human immune systems. This is all good stuff.
When ENZC does start aggressively marketing the product, that should be the start of the revenue stream. As I read it, the balance of the $1m of the distribution agreement will probably not be recognized until the clinical trials and permitting are completed. The value of the 50% ownership of the manufacturing plant will be recognized as well. Please don't set unrealizable expectations.
Onward!
Bingo! MAGA hits it out of the park.
This is the information - information! not speculation - that all of us love to see.
Savov - more thoughts:
Looks to me like Savov has taken shares of ENZC he is not entitled to and ENZC is trying to get them back with their Delaware claim - protecting us shareholders.
And, they are pursuing criminal charges in Bulgaria
Savov claims to want 2 million Euros, but to my knowledge, there is no document that he invested anything. How do people justify believing self serving lies?
Where is the public filing reviewed by the OTC and other professionals? Where is the DD? Where are the breadcrumbs? If there was a study in Bulgaria on ITV-1, where is it published?
Looks to me like ENZC (and previously Harry and IMMB) are the victims. Why would a victim settle?
Charles and Harry have stood firm not caving to threats and attempts at extortion. There wil be no settlement in my opinion. ENZC and IMMB are all in. The only thing Savov can do is to interfere with the ENZC business plan and make comments scaring shareholders. No leverage.
Savov needs to step up - there's too much yak, yah
1) Savov has been sued in the chancellory court of Delaware
2) Savov has been served with a criminal complaint in Bulgaria
3) Savov has been declared "mentally incompetent" to participate in a judicial hearing where he was to be a witness against individuals charged with bank fraud.
4) Savov is facing complaints in Sofia for making slanderous and libelous statements against a respected Senator of Bulgaria
5) Savov denied entry into the US?
If Savov wants to beat the claim filed by ENZC, he can answer any complaint in court in Delaware by presenting his facts as to the ownership of the 71 million shares, rather than avoiding service.
These actions look like the last gasp of a con man trying to keep his foot in the door when he has been rightfully kicked to the curb. Desperation.
Christmas trees with gifts are green.
Red is the color of emotion...
GREEN is the color of success - breadcrumbs: signed agreements with Samsung, PR's announcing new initiatives and tweets hinting at future announcements.
No, this is exciting!
Some people cannot see excitement and positivity if it bit them in the nose.
Onward!
Hey hey hey - a PR....Finally!
Here the main point: Whether the price goes up or down ENZC is making progress - serious progress. Here is the proof.
Eventually, investors will catch up and the short shifters will succumb to their own sinkhole attitude. We longs will prevail.
Onward!